Neuropsychopharmacology Reports最新文献

{"title":"Facial Emotional Expression in Reaction to Internet Gaming Videos Among Young Adults: A Preliminary and Exploratory Study.","authors":"Nanase Kobayashi, Daisuke Jitoku, Masato Nishihara, Yuka Fujimoto, Chenyu Qian, Shoko Okuzumi, Shisei Tei, Takehiro Tamura, Hidehiko Takahashi, Takefumi Ueno, Makiko Yamada, Junya Fujino","doi":"10.1002/npr2.70031","DOIUrl":"10.1002/npr2.70031","url":null,"abstract":"<p><p>The surge in online gaming's popularity has raised concerns regarding excessive engagement particularly among younger generations. Internet gaming disorder (IGD) is increasingly recognized as a clinical concern, underscoring the necessity for early detection and intervention. Although facial expressions provide key emotional insights, their link to symptoms associated with internet gaming addiction remains largely unexplored. In this preliminary study, we investigated facial emotional expressions in response to internet gaming videos among 28 young adults who casually play online games, utilizing the automated facial expression recognition system for analysis. Participants watched internet gaming and neutral (nongaming) videos while their facial expressions were recorded. We measured the intensity of each facial expression (happy, sad, angry, surprised, scared, disgusted, and neutral) and explored their correlation with symptoms related to internet gaming addiction. Participants exhibited a higher intensity of neutral expression and a lower intensity of sad expression in internet gaming videos compared to neutral ones; however, the findings were only nominally significant and did not survive correction for multiple comparisons. Moreover, participants with higher symptoms of internet gaming addiction displayed reduced facial intensity of sadness in response to internet gaming videos. Additionally, we noted a positive correlation between the facial intensity of surprise and levels of gaming desire. Furthermore, the intensity of disgusted facial expressions showed a negative correlation with participants' familiarity levels with the online games. These preliminary and exploratory findings hold promise for deepening our understanding of individuals' emotional responses and internet gaming behavior. Future research with larger samples, including patients with IGD, will be crucial to validate these findings and to inform the development of preventive strategies and effective interventions in this field.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 2","pages":"e70031"},"PeriodicalIF":2.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144285792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment Persistence of Paliperidone Palmitate 3-Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis.","authors":"Akihide Wakamatsu, Madoka Chinen, Hiroshi Horio, Chih-Lin Chiang, Natsuko Tokushige, Yosuke Saga","doi":"10.1002/npr2.70019","DOIUrl":"10.1002/npr2.70019","url":null,"abstract":"<p><strong>Aim: </strong>To examine treatment persistence rates of paliperidone palmitate 3-month (PP3M) for schizophrenia in Japan because evidence in real-world settings is limited.</p><p><strong>Methods: </strong>A retrospective population-based cohort study was conducted using the Japan Medical Data Center claims database. The overall cohort comprised schizophrenia patients aged ≥ 18 years, who received paliperidone palmitate 1-month (PP1M) within 180 days before initiating PP3M. Of patients in the overall cohort, those who received PP1M ≥ 4 times within 180 days at 21-42-day intervals with the same dosage strength as the last two PP1M doses before switching to PP3M initiated PP3M with a dose equivalent to 3.5-fold the last PP1M dose and took no other concomitant antipsychotics within 112 days before initiating PP3M were included in the per protocol cohort (PPC). The Kaplan-Meier method was used to calculate PP3M persistence rates in the overall cohort and PP3M monotherapy persistence rates in the PPC.</p><p><strong>Results: </strong>In the overall cohort and PPC, 121 patients and 87 patients, with a mean age of 41.5 years and 48%-53% being employed, were followed up for ≤ 27 months. At 365 days and 730 days, the PP3M persistence rate was 76.9% and 71.7% in the overall cohort, and that for PP3M monotherapy was 73.1% and 64.6% in the PPC.</p><p><strong>Conclusion: </strong>Treatment persistence rates for PP3M in Japan were relatively high among schizophrenia patients transitioned from PP1M. High persistence rates can be achieved with PP3M monotherapy in patients who have been sufficiently stabilized with PP1M monotherapy prior to initiating PP3M.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 2","pages":"e70019"},"PeriodicalIF":2.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144002698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of Over-the-Counter Drug Abuse and Associated Psychosocial Factors Among High School Students: A Nationwide Cross-Sectional Survey in Japan.","authors":"Takuya Shimane, Satoshi Inoura, Maki Kitamura, Kunihiko Kitagaki, Koji Tominaga, Toshihiko Matsumoto","doi":"10.1002/npr2.70030","DOIUrl":"10.1002/npr2.70030","url":null,"abstract":"<p><strong>Aim: </strong>This study estimated the prevalence of over-the-counter (OTC) drug abuse among high school students in Japan and clarified the predictors related to their school and home life.</p><p><strong>Methods: </strong>A nationwide cross-sectional survey was conducted between September 2021 and March 2022. The survey included 41 357 valid responses from 202 randomly selected regular high schools in Japan. Respondents were asked about their history of OTC drug abuse within the past year, which was the primary outcome of this study. Multivariate logistic regression analyses were performed to identify the predictors of OTC drug abuse.</p><p><strong>Results: </strong>The estimated prevalence of OTC drug abuse over the past year was 1.5% (95% CI: 1.4-1.6). Dissatisfaction with school life (AOR = 2.57, 95% CI = 1.80-3.66), hours spent in a day without parents (AOR = 1.59, 95% CI = 1.27-2.00), and COVID-19-related stress (AOR = 1.53, 95% CI = 1.14-2.05) significantly increased the risk of OTC drug abuse. Conversely, positive extracurricular activities (AOR = 0.80, 95% CI = 0.63-1.00), close communication with the mother (AOR = 0.66, 95% CI = 0.51-0.87), and high drug-refusal skills (AOR = 0.57, 95% CI = 0.41-0.79) significantly reduced the risk.</p><p><strong>Conclusions: </strong>OTC drug abuse is widespread among high school students in Japan, and attention should be paid to students who are isolated at school and home. Therefore, it is important to develop effective prevention, education, and treatment programs for adolescents that consider the risks and protective factors associated with OTC drug abuse.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 2","pages":"e70030"},"PeriodicalIF":2.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144294147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Candidate Anxiety-Related Genes in the Hippocampus of Hatano Male Rats: Anxiolytic Action of Neuromedin U in the Hippocampus.","authors":"Kaito Sato, Atsuhiro Ishii, Shohei Kobayashi, Taichi Hatakeyama, Gen Watanabe, Tomoko Soga, Ishwar Parhar, Takashi Matsuwaki, Shogo Moriya, Ryo Ohta, Shuichi Chiba, Maiko Kawaguchi","doi":"10.1002/npr2.70018","DOIUrl":"10.1002/npr2.70018","url":null,"abstract":"<p><p>Identifying genes involved in anxiety is important to elucidate the mechanisms of anxiety disorders. Hatano high avoidance animals (HAA) and low avoidance animals (LAA) are inbred strains that are selected based on their performance in an active avoidance test. HAA shows a higher level of anxiety-like behavior than LAA. The present study focuses on the hippocampus, which is associated with anxiety-like behavior, and used microarray analysis and RT-qPCR to select genes with differential expression in the hippocampus between HAA and LAA (Experiment 1). The microarray analysis revealed differences in 498 gene expressions between HAA and LAA, of which 21 genes were ligand-receptor related in the nervous system. We selected nine genes based on p value and conducted RT-qPCR, which identified seven genes whose expressions were higher in LAA than in HAA. We focused on the gene, neuromedin U receptor 2 (Nmur2), which showed significantly different expression levels between HAA and LAA. Further, we conducted a behavioral test to evaluate anxiety levels by administering neuromedin U (NmU), an agonist for NmUR2, into the hippocampus (Experiment 2). NmU treatment did not affect the results of the open field test or the elevated plus maze test, which are unconditioned response models of anxiety. However, in the passive avoidance test, a conditioned response model of anxiety, the NmU group showed less anxiety-like behavior than the control group. This is the first study to show that NmU suppresses the conditioned response model of anxiety via the hippocampus, indicating that NmUR2 in the hippocampus may be involved in anxiety-like behavior.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 2","pages":"e70018"},"PeriodicalIF":2.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12022414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144037579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Longitudinal Study of the Association of Blood Unsaturated Fatty Acids With Posttraumatic Stress Disorder (PTSD).","authors":"Tomoko Inoue, Shintaro Ogawa, Zui Narita, Masayuki Sekiguchi, Yasushi Asari, Yuichi Kataoka, Jun Hattori, Hiroaki Hori, Yoshiharu Kim, Ken Inada","doi":"10.1002/npr2.12522","DOIUrl":"10.1002/npr2.12522","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to investigate the association between blood fatty acid fractions and posttraumatic stress disorder (PTSD) judgment in individuals who have experienced physical trauma.</p><p><strong>Methods: </strong>Patients admitted to the emergency department for trauma, excluding those with brain damage or serious psychiatric disorders, were enrolled. Blood samples were collected on admission, and PTSD symptoms were assessed using a questionnaire 1 and 3 months after the injury. Multiple regression analysis was used to evaluate the association between fatty acids and Posttraumatic Diagnostic Scale severity scores, adjusting for age, sex, the Childhood Trauma Questionnaire (CTQ), and the use of psychotropic medications.</p><p><strong>Results: </strong>A significant association was observed between certain fatty acids and PTSD judgment. Mann-Whitney U test results revealed that arachidonic acid was associated with PTSD judgment at 1 month and palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, eicosenoic acid, and eicosadiene acid with PTSD judgment at 3 months. Multiple regression analysis revealed that stearic acid, linoleic acid, arachidic acid, docosatetraenoic acid, lignoceric acid, docosahexaenoic acid, and total omega-6 fatty acids (ω6) were associated with PTSD judgment after 1 month after trauma. In contrast, only linoleic acid and total ω6 were associated with PTSD judgment 3 months after trauma.</p><p><strong>Conclusions: </strong>This study is the first to enroll patients with general physical trauma and examine the relationship between fatty acids and PTSD. The findings suggest a potential relationship between blood fatty acid fractions and the development of PTSD symptoms in individuals who have experienced physical trauma. However, further research is needed to confirm and expand on these findings.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 1","pages":"e12522"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143441474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association Analysis of Rare CNTN5 Variants With Autism Spectrum Disorder in a Japanese Population.","authors":"Abdul Fuad Hadi, Reza K Arta, Itaru Kushima, Jun Egawa, Yuichiro Watanabe, Norio Ozaki, Toshiyuki Someya","doi":"10.1002/npr2.12527","DOIUrl":"10.1002/npr2.12527","url":null,"abstract":"<p><strong>Background: </strong>Contactin-5 (CNTN5), a neural adhesion molecule involved in synaptogenesis and synaptic maturation in the auditory pathway, has been associated with the pathophysiology of autism spectrum disorder (ASD), particularly hyperacusis. To investigate the role of rare CNTN5 variants in ASD susceptibility, we performed resequencing and association analysis in a Japanese population.</p><p><strong>Methods: </strong>We resequenced the CNTN5 coding regions in 302 patients with ASD and prioritized rare putatively damaging variants. The prioritized variants were then genotyped in 313 patients with ASD and 1065 controls. Subsequently, we conducted an association study of selected variants with ASD in 614 patients with ASD and 61 057 controls. Clinical data were reviewed for patients carrying prioritized variants.</p><p><strong>Results: </strong>Through resequencing, we prioritized three rare putatively damaging missense variants (W69G, I227L, and L1000S) in patients with ASD. Although we found a nominally significant association between the I227L variant and ASD, it did not remain significant after post hoc correction. Hyperacusis was found in three out of nine patients carrying prioritized variants.</p><p><strong>Conclusion: </strong>This study does not provide evidence for the contribution of rare CNTN5 variants to the genetic etiology of ASD in the Japanese population.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 1","pages":"e12527"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143067001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between psychological distress and schizotypy in adults: A cross-sectional study.","authors":"Hiroyuki Uchida, Sae Ohki, Chiaki Kuroiwa, Kenji Tsuchiya, Senichiro Kikuchi, Kazuki Hirao","doi":"10.1002/npr2.12511","DOIUrl":"10.1002/npr2.12511","url":null,"abstract":"<p><strong>Background: </strong>Schizotypy refers to a personality type characterized by behavioral and cognitive abnormalities similar in nature but less severe than those of schizophrenia. Schizotypy often progresses to schizophrenia, so identifying risk factors may facilitate early schizophrenia diagnosis and improve treatment. Psychological distress may be associated with schizotypy, highlighting its importance. However, the link between psychological distress and schizotypy remains unclear.</p><p><strong>Methods: </strong>This cross-sectional study examined the relationship between schizotypy and psychological distress in a Japanese adult population using internet-based questionnaires. Schizotypy was assessed using the Schizotypal Personality Questionnaire-Brief and psychological distress was measured using the Kessler Screening Scale for Psychological Distress. Multivariate logistic regression analysis was used to assess the relationship between psychological distress and schizotypy after adjusting for numerous potential confounding variables.</p><p><strong>Results: </strong>Among 6632 participants, 225 were classified with schizotypy (3.39%, 89 females [39.6%]). Multivariate logistic regression analysis adjusting for confounding factors revealed that participants with psychological distress were significantly more likely to exhibit signs of schizotypy than those without psychological distress (adjusted odd ratio, 2.91; 95% confidence interval, 1.85-4.59).</p><p><strong>Conclusions: </strong>The emergence of schizotypy in adults is strongly associated with psychological distress. This finding emphasizes the need for physicians to carefully, thoroughly, and routinely assess psychological distress in adults. Longitudinal studies are warranted to investigate the causal relationship between schizotypy and psychological distress.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":" ","pages":"e12511"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142896339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review.","authors":"Michał Pastuszak, Wiesław Jerzy Cubała, Katarzyna Jakuszkowiak-Wojten, Aleksander Kwaśny, Damian Świeczkowski, Maria Gałuszko-Węgielnik","doi":"10.1002/npr2.12519","DOIUrl":"10.1002/npr2.12519","url":null,"abstract":"<p><strong>Background: </strong>Residual fatigue is a common and debilitating symptom in patients with unipolar and bipolar depression, even after achieving partial or full remission. It significantly impacts patients' quality of life and increases the risk of relapse. This systematic review aims to evaluate the prevalence and effectiveness of therapeutic options for residual fatigue in individuals with unipolar major depressive disorder (MDD) and bipolar disorder (BD).</p><p><strong>Methods: </strong>A comprehensive search was conducted in the PubMed, SCOPUS, and Web of Science databases up to September 2024. The protocol for this systematic review was registered in PROSPERO. The search strategy included terms related to depression and residual fatigue. Studies were included if they provided data on adult patients diagnosed with MDD or BD, and if they measured the prevalence or treatment of residual fatigue. Risk of bias was assessed using the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Scale for non-randomized studies.</p><p><strong>Results: </strong>Twenty studies were included in the review. The vast majority reported on MDD, and single papers investigated BD. Residual fatigue was reported by up to 83% of patients, and moderate to severe residual fatigue affected a smaller percentage. Pharmacological treatments, such as modafinil and to a lesser extent atomoxetine, demonstrated short-term reductions in residual fatigue.</p><p><strong>Conclusion: </strong>Residual fatigue remains a significant challenge in the treatment of depression, persisting in a large portion of patients despite remission. Pharmacological interventions like modafinil appear promising, but more research is needed, especially in BD. Standardized assessment tools and longer-term studies are essential to better understand and treat residual fatigue.</p><p><strong>Trial registration: </strong>PROSPERO identifier: CRD42024543087.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 1","pages":"e12519"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142952408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment.","authors":"Shinichiro Ochi, Takashi Tsuboi, Naomi Hasegawa, Hikaru Hori, Kayo Ichihashi, Yayoi Imamura, Tsuyoshi Okada, Fumitoshi Kodaka, Yoshitaka Saito, Jun-Ichi Iga, Toshiaki Onitsuka, Kiyokazu Atake, Shu-Ichi Ueno, Ryota Hashimoto, Norio Yasui-Furukori","doi":"10.1002/npr2.12499","DOIUrl":"10.1002/npr2.12499","url":null,"abstract":"<p><strong>Aim: </strong>Constipation is one of the most common adverse effects in schizophrenia treatment, and it can sometimes cause severe gastrointestinal disease. However, the results of association studies between constipation and psychotropic medications in patients with schizophrenia are inconsistent. Therefore, we investigated the characteristics of psychotropic and laxative prescriptions at discharge in patients with schizophrenia to clarify the association between psychotropics and constipation.</p><p><strong>Methods: </strong>We analyzed the data of 139 patients with schizophrenia with or without laxative prescriptions at discharge from eight institutions in 2020.</p><p><strong>Results: </strong>Sixty-two patients were prescribed laxatives at discharge. The prescription of benzodiazepines in the laxative use group (66.1%) was significantly higher than that in the non-laxative use group (39.0%) (p = 1.4 × 10^-3), and the mean number of benzodiazepines in the laxative use group (1.2 ± 1.1/day) was significantly higher than that in the non-laxative use group (0.7 ± 0.9/day) (p = 2.6 × 10^-3). Multivariate logistic regression analyses revealed that benzodiazepine prescriptions were significantly associated with laxative usage (odds ratio, 3.059; 95% confidence interval, 1.523-6.144; p = 2.0 × 10^-3).</p><p><strong>Conclusion: </strong>Benzodiazepines may be associated with constipation in patients with schizophrenia. Therefore, clinicians should be cautious when prescribing benzodiazepines for the treatment of schizophrenia.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":" ","pages":"e12499"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders.","authors":"Yuka Yasuda, Satsuki Ito, Junya Matsumoto, Naohiro Okada, Toshiaki Onitsuka, Masashi Ikeda, Itaru Kushima, Chika Sumiyoshi, Masaki Fukunaga, Kiyotaka Nemoto, Kenichiro Miura, Naoki Hashimoto, Kazutaka Ohi, Tsutomu Takahashi, Daiki Sasabayashi, Michihiko Koeda, Hidenaga Yamamori, Michiko Fujimoto, Harumasa Takano, Naomi Hasegawa, Hisashi Narita, Maeri Yamamoto, Khin Khin Tha, Masataka Kikuchi, Toshiharu Kamishikiryo, Eri Itai, Yoshiro Okubo, Amane Tateno, Motoaki Nakamura, Manabu Kubota, Hiroyuki Igarashi, Yoji Hirano, Go Okada, Jun Miyata, Shusuke Numata, Osamu Abe, Reiji Yoshimura, Shin Nakagawa, Hidenori Yamasue, Norio Ozaki, Kiyoto Kasai, Ryota Hashimoto","doi":"10.1002/npr2.70010","DOIUrl":"10.1002/npr2.70010","url":null,"abstract":"<p><p>One of the challenges in diagnosing psychiatric disorders is that the results of biological and neuroscience research are not reflected in the diagnostic criteria. Thus, data-driven analyses incorporating biological and cross-disease perspectives, regardless of the diagnostic category, have recently been proposed. A data-driven clustering study based on subcortical volumes in 5604 subjects classified into four brain biotypes associated with cognitive/social functioning. Among the four brain biotypes identified in controls and patients with schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder, and other psychiatric disorders, we further analyzed the brain biotype 1 subjects, those with an extremely small limbic region, for clinical utility. We found that the representative feature of brain biotype 1 is enlarged lateral ventricles. An enlarged ventricle, defined by an average z-score of left and right lateral ventricle volumes > 3, had a sensitivity of 99.1% and a specificity of 98.1% for discriminating brain biotype 1. However, the presence of an enlarged ventricle was not sufficient to classify patient subgroups, as 1% of the controls also had enlarged ventricles. Reclassification of patients with enlarged ventricles according to cognitive impairment resulted in a stratified subgroup that included patients with a high proportion of schizophrenia diagnoses, electroencephalography abnormalities, and rare pathological genetic copy number variations. Data-driven clustering analysis of neuroimaging data revealed subgroups with enlarged ventricles and cognitive impairment. This subgroup could be a new diagnostic candidate for psychiatric disorders. This concept and strategy may be useful for identifying biologically defined psychiatric disorders in the future.</p>","PeriodicalId":19137,"journal":{"name":"Neuropsychopharmacology Reports","volume":"45 1","pages":"e70010"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11864853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143516263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}